The Berlin-Brandenburg BioRegion…
…a Leading Hub for Life Sciences
The Berlin-Brandenburg region is one of the leading international locations for life sciences. The area is known for clinical research via a dense and compact healthcare network, and boasts a state-of-the-art IT infrastructure. It is no coincidence that the region is Germany’s ‘health capital’ as it is home to both the German government, as well as the center for healthcare industries.
The region’s distinction is anchored in its unique research and clinical landscape, as well as its ability to closely link the key players in life sciences and healthcare. Biotechnology, in particular, is a strong driving force within the Berlin-Brandenburg healthcare industries cluster – HealthCapital – generating innovation and growth there and beyond. Through networking the pharmaceutical, diagnostics and medical technology sectors completely new fields of business are created. More than 220 biotechnology and around 30 pharmaceutical companies are located in the German Capital Region. They include market leaders like Bayer HealthCare, Bausch & Lomb, B. Braun Melsungen, Berlin-Chemie, Pfizer, Sanofi and Takeda. Along with the sector’s many small and mid-sized companies, they benefit from close cooperation, both with science and with more than 130 hospitals – above all, one of Europe’s largest university hospitals: Charité – Universitätsmedizin Berlin. Customers from research and industry have access to patient cohorts of urban and rural populations of about 180 ethnicities, covering all medical indications. The many technology parks and networks in the various branches of modern biotechnology create the excellent infrastructure and technological support that characterize the Berlin-Brandenburg biotech area. Focus areas of activity within the region are biomedicine and diagnostics, therapeutics and regenerative medicine as well as industrial biotechnology.
…connected to the European Hotspots
Active cooperation in the networks of Europe’s BioRegions has played a central role in the internationalisation efforts in the region. BioTOP Berlin-Brandenburg is a founding member of the Council of European Bioregions (CEBR) and ScanBalt – the biotech network of the Baltic Sea states. Through the Center for Molecular Diagnostics and Bioanalytics (ZMDB), the region is also a founding member of the still young European Diagnostic Clusters Alliance (EDCA), a network of leading European diagnostics clusters which currently represents more than 400 companies from the member regions. As the only German region in this network to date, Berlin-Brandenburg is regarded as one of the most high-performing regions in the alliance as regards both the number of companies and research facilities engaged in diagnostics development and the structures already established here.
…offering Service and Support for Biotechnology in the Capital Region
The central contact and coordination office for all issues concerning biotechnology in the German Capital Region is BioTOP – a joint initiative of the federal states of Berlin and Brandenburg in the Berlin Partner for Business and Technology GmbH and part of the regional healthcare industries cluster HealthCapital. It is the objective of BioTOP to coordinate all regional activities in biotechnology by networking with all key players and to initiate specific projects in order to extend the region’s leading position in biotechnology and life sciences worldwide.